Comparison of ramosetron dose in postoperative nausea and vomiting receiving oxycodone based intravenous patient-controlled analgesia undergoing gynecological laparoscopic surgery

Comparison of ramosetron dose in postoperative nausea and vomiting receiving oxycodone based intravenous patient-controlled analgesia undergoing gynecological laparoscopic surgery - A prospective randomized controlled study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0001745

Enrollment

Registered

2015-12-30

Start date

2014-04-17

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Oxycodone (5 mg) and ramosetron (0.3 mg) were injected to regulate pain 5 min after the end of the operation. IV PCA was divided randomly into the RB and RM groups. The group RB received 10 ml

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: American Society of Anaesthesiologists physical status 1 or 2 female patients 18–70 years old receiving laparoscopic partial hysterectomy

Exclusion criteria

Exclusion criteria: pregnancy, obesity, history of Postoperative nausea and vomiting, bleeding tendency, mental disorder, hepatitis or renal failure, and recent history of taking steroids or antiemetics.

Design outcomes

Primary

Measure	Time frame
PONV	—

Secondary

Measure	Time frame
Pain score	—

Countries

Korea, Republic of

Contacts

Public ContactHyungYoun Gong

Soon Chun Hyang University Hospital Cheonan

hgriffin@naver.com

Outcome results